Many studies have demonstrated that PI3K/Akt pathway is activated in 40-50% of HCC patients and plays a critical role in cell growth and metabolism, ultimately affecting the invasion, metastasis, and invasiveness of cancer cells (60, 61). Here, AKT1 is linked to hepatocellular carcinoma.